Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Pediatric Cardiology

Finding the Cause: Idiopathic vs. Structural Issues

At a Glance

Incessant Infant Ventricular Tachycardia (IIVT) is typically caused by either an electrical issue in a structurally normal heart (idiopathic) or hidden physical abnormalities like tiny cellular clusters (structural). Doctors use cardiac MRIs and genetic testing to uncover the exact cause.

When doctors begin investigating Incessant Infant Ventricular Tachycardia (IIVT), their primary goal is to determine why the heart’s lower chambers are beating so fast. They generally categorize the cause into two groups: idiopathic (no visible structural cause) or structural (caused by a physical change in the heart tissue) [1][2].

Idiopathic vs. Structural: What’s the Difference?

A structurally normal heart means that on standard tests like an ultrasound (echocardiogram), the heart’s walls, valves, and chambers look perfectly shaped and healthy [3]. In these cases, the fast rhythm is usually a “purely electrical” problem—like a glitch in a computer’s software rather than a broken piece of hardware [2].

However, some infants have structural causes. These are physical issues in the heart muscle that act as “spark plugs,” constantly firing off electrical signals that cause the heart to race [4][5]. One specific type is a Purkinje cell hamartoma (also called histiocytoid cardiomyopathy). These are tiny, benign (non-cancerous) clusters of abnormal cells that are often too small to see on a standard ultrasound [4]. Despite being small, they are electrically active and can drive the heart into a continuous fast rhythm [5].

The Diagnostic Toolkit

To find these hidden causes, the medical team uses a “deep dive” approach:

  • 12-Lead ECG and Holter Monitor: These are the first steps. An ECG (electrocardiogram) provides a snapshot of the heart’s electrical activity, while a Holter monitor records every heartbeat for 24–48 hours to see just how “incessant” the rhythm really is [2].
  • Cardiac MRI (CMR): This is vital because ultrasound often misses microscopic masses like hamartomas [6]. A Cardiac MRI uses high-resolution imaging and a special dye called gadolinium to highlight tiny areas of scarring or unusual tissue (known as late gadolinium enhancement) that could be the source of the arrhythmia [7][8].
  • Genetic Sequencing: Even in a heart that looks normal on every scan, the “blueprint” of the heart cells might be the cause [9]. Genetic testing looks for mutations in genes like SCN5A or RYR2, which control how electricity moves through the heart [10]. Identifying a specific mutation can change the treatment plan, as certain drugs work better for specific genetic glitches [11].

Why “Normal” Isn’t Always the Whole Story

It can be confusing when a doctor says the heart looks “structurally normal” but still orders more tests. This is because “normal” on an ultrasound doesn’t rule out occult (hidden) heart disease [3][12]. Finding the exact cause—whether it’s a genetic channel issue or a tiny cellular tumor—is the key to moving from temporary medications to a permanent cure [2][4].

Common questions in this guide

What is the difference between idiopathic and structural infant ventricular tachycardia?
Idiopathic IIVT means the heart appears physically normal on standard tests, and the rapid heartbeat is due to a purely electrical issue. Structural IIVT is caused by physical changes or abnormalities in the heart tissue that trigger the fast rhythm.
Why does my baby need a cardiac MRI if their echocardiogram was normal?
Standard ultrasounds can miss microscopic issues like tiny clusters of abnormal cells. A cardiac MRI provides high-resolution images and uses a special dye to reveal hidden tissue abnormalities that might be causing the arrhythmia.
What is a Purkinje cell hamartoma?
A Purkinje cell hamartoma, also known as histiocytoid cardiomyopathy, is a tiny, non-cancerous cluster of abnormal cells in the heart muscle. Even though they are small, these cells are highly active electrically and can drive the heart into a continuous fast rhythm.
Can genetic testing help diagnose the cause of my baby's fast heart rate?
Yes, genetic testing looks for specific mutations in the 'blueprint' of the heart cells that control how electricity moves through the heart. Identifying a genetic glitch can help doctors tailor a more effective treatment plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was any 'bright' or unusual-looking tissue seen on the initial echocardiogram?
  2. 2.If the heart looks structurally normal on the ultrasound, why is a cardiac MRI still necessary for my baby?
  3. 3.Will my baby need to be sedated or anesthetized for the MRI, and how will their heart rhythm be monitored during the scan?
  4. 4.If the genetic testing finds a mutation, does that mean I or my other children need to be tested?
  5. 5.What is the difference in treatment if we find a 'hamartoma' versus if the cause is 'idiopathic'?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Incessant Ventricular Tachycardia in Infant With Structurally Normal Heart: Is it Truly Benign or a Old Wives' Tale.

    Mohsin M, Sangi R, Sheikh AS

    Sage open pediatrics.. 2025; (12()):30502225251319869 doi:10.1177/30502225251319869.

    PMID: 40612172
  2. 2

    Successful ablation of incessant idiopathic right ventricular tachycardia arising from unusual sites in children.

    Wu L, Tian H, Wang F, et al.

    Cardiology in the young 2016; (26(4)):764-71 doi:10.1017/S1047951115001341.

    PMID: 26165382
  3. 3

    Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice : A state-of-the-art review by the American College of Cardiology Electrophysiology Council.

    Gorenek B, Fisher JD, Kudaiberdieva G, et al.

    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2020; (57(1)):5-26 doi:10.1007/s10840-019-00655-3.

    PMID: 31828560
  4. 4

    A Case of Ventricular Tachycardia Caused by a Rare Cardiac Mesenchymal Hamartoma.

    Feng Z, Philipson D, Uzzell JP, et al.

    JACC. Case reports 2020; (2(7)):1049-1055 doi:10.1016/j.jaccas.2020.04.038.

    PMID: 34317413
  5. 5

    Ventricular tachycardia in the setting of a large cardiac fibroma in a pediatric patient.

    O'Neal J, Ferns S, Andrews WG, Shillingford M

    Indian pacing and electrophysiology journal 2023; (23(1)):34-37 doi:10.1016/j.ipej.2022.12.002.

    PMID: 36526240
  6. 6

    Cardiac MRI: An Overview of Physical Principles With Highlights of Clinical Applications and Technological Advancements.

    Stoltzfus MT, Capodarco MD, Anamika F, et al.

    Cureus 2024; (16(3)):e55519 doi:10.7759/cureus.55519.

    PMID: 38576652
  7. 7

    Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging.

    Kassi M, Polsani V, Schutt RC, et al.

    The Journal of thoracic and cardiovascular surgery 2019; (157(5)):1912-1922.e2 doi:10.1016/j.jtcvs.2018.09.057.

    PMID: 30551963
  8. 8

    Differential and prognostic value of cardiovascular magnetic resonance derived scoring algorithm in cardiac tumors.

    Yue P, Xu Z, Wan K, et al.

    International journal of cardiology 2021; (331()):281-288 doi:10.1016/j.ijcard.2021.01.068.

    PMID: 33582195
  9. 9

    Generation of an iPSC cell line (VANYHHi001-A) from a patient with cardiac arrythmias carrying CACNA1D, SCN5A, and DSP variants.

    Sleiman Y, Reisqs JB, Bianca Tan R, et al.

    Stem cell research 2024; (81()):103608 doi:10.1016/j.scr.2024.103608.

    PMID: 39551029
  10. 10

    Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.

    Seidlmayer LK, Riediger F, Pagonas N, et al.

    Journal of medical case reports 2018; (12(1)):298 doi:10.1186/s13256-018-1825-6.

    PMID: 30296944
  11. 11

    Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.

    Bergeman AT, Lieve KVV, Kallas D, et al.

    Circulation 2023; (148(25)):2029-2037 doi:10.1161/CIRCULATIONAHA.123.064786.

    PMID: 37886885
  12. 12

    Evolution of Deceleration Zones During Ventricular Tachycardia Ablation and Relation With Cardiac Magnetic Resonance.

    Vázquez-Calvo S, Casanovas JM, Garre P, et al.

    JACC. Clinical electrophysiology 2023; (9(6)):779-789 doi:10.1016/j.jacep.2022.12.015.

    PMID: 37380313

This page provides educational information about the causes of infant ventricular tachycardia and does not constitute medical advice. Always consult a pediatric cardiologist or electrophysiologist regarding your child's specific diagnosis and treatment.

Get notified when new evidence is published on Incessant infant ventricular tachycardia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.